Ann: Norwest Directors Unanimously Recommend MinRes' Revised Offe, page-261

First 261 Last

Share
Profile

Follow
Mondo1960

966 Posts.

147

26/01/23

12:54

Post #: 65892720
Share

Originally posted by RedRooster2: ↑

No certainty if MinRes & Hancock are working together, but thinking they have the same strategy as NWE holders, strength in numbers, could be double teaming ?
The objective is Erregulla gas fields & NWE 2 permit share.
Possibly Consolidating a huge gas resource for them to share the spoils and the considerable costs to get to production.
Friend or foe either way this could be a huge boon for NWE, we could become leverage Tool in future acquisitions and negotiations and that could be very beneficial.
This also fits in with the increased share trading activity, especially the feeding that happened yesterday, many shares changed hands, whose hands is the question?
Many have motive to get on the NWE share register and that may not be to TO, but to gain important leverage in future negotiations.
It is a very BIG game shaping up and it looks to me it could all become a bit complicated before it sorted. Could even be a new comer emerging, now that would shake it all up.
Best option for me and I reckon others is to definitely hold until more certainty is established.
I do think there is much more to come yet !!!

My opinion only
GLAH

Expand

whoever is buying on market is paying cash for NWE shares so IMHO unlikely to be MIN
The MIN bid is a share swap so this happens off market
Agree the big question is who is buying?
All on market buyers have their own agendas
I think the big buyer is Gina because she
wants WGO and MIN has a 19% blocking stake
not interested in swapping her NWE shares for MIN shares [boring]
wants to gain leverage against MIN so she can swap her NWE shares for MIN's WGO shares
AIMHO & DYOR

NWE Price at posting: 7.2¢ Sentiment: Hold Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

HAS

Hastings progressing Yangibana to production with lower costs

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ZNC

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

The iron ore comeback: Can it last?